Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparative Evaluation of Standard Prophylaxis Versus Divided-dose NSAIDs or Hybrid NSAID and N-acetylcysteine Therapy for the Prevention of Post-ERCP Pancreatitis

NCT03708458 is registered in ClinicalTrials.gov with Grigore T. Popa University of Medicine and Pharmacy as lead sponsor.

NCT NCT03708458
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03708458 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparative Evaluation of Standard Prophylaxis Versus Divided-dose NSAIDs or Hybrid NSAID and N-acetylcysteine Therapy for the Prevention of Post-ERCP Pancreatitis
Lead sponsor
Grigore T. Popa University of Medicine and Pharmacy
Phase
Phase 4
Overall status
Unknown status
Start date
April 1, 2017
Completion date
December 15, 2018
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp pancreatitis